Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in Solid Organ Transplantation Final Report
Open Access
- 1 February 2005
- journal article
- review article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 5 (2), 218-227
- https://doi.org/10.1111/j.1600-6143.2004.00692.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2004
- Cytomegalovirus (CMV) Virus Load Kinetics to Predict Recurrent Disease in Solid‐Organ Transplant Patients with CMV DiseaseThe Journal of Infectious Diseases, 2002
- Delayed Occurrence of Cytomegalovirus Disease in Organ Transplant Recipients Receiving Antiviral Prophylaxis: Are We Winning the Battle Only to Lose the War?European Journal of Clinical Microbiology & Infectious Diseases, 2002
- Combination Antiviral Therapy for Ganciclovir‐Resistant Cytomegalovirus Infection in Solid‐Organ Transplant RecipientsClinical Infectious Diseases, 2002
- Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsClinical Infectious Diseases, 2002
- Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant RecipientsJournal of Clinical Microbiology, 2002
- Prophylaxis for CMV should not now replace pre‐emptive therapy in solid organ transplantationReviews in Medical Virology, 2001
- Cytomegalovirus (CMV) DNA Load Predicts Relapsing CMV Infection after Solid Organ TransplantationThe Journal of Infectious Diseases, 2000
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Late-acute renal allograft rejection and symptomless cytomegalovirus infectionThe Lancet, 1994